Lupin has reported results for second quarter ended September 30, 2015.
The company has reported 7.44% rise in its net profit at Rs 493.80 crore for the quarter ended September 30, 2015 as compared to Rs 459.62 crore for the same quarter in the previous year. The company’s total income has increased by 9.97% to Rs 2581.91 crore for the quarter under review from Rs 2347.83 crore for the corresponding quarter of the previous year.
On the consolidated basis, the company has reported 35.11% fall in its net profit/(loss) after taxes, minority interest at Rs 408.84 crore for the quarter ended September 30, 2015 as compared to Rs 630.04 crore for the same quarter in the previous year. However, total income of the company has increased marginally by 2.41% at Rs 3362.76 crore for quarter under review as compared to Rs 3283.64 crore for the quarter ended September 30, 2014.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1532.85 |
Dr. Reddys Lab | 5812.50 |
Cipla | 1403.90 |
Zydus Lifesciences | 1104.45 |
Lupin | 1661.90 |
View more.. |